View drug registration information details.


ItemsRegistration information
ID1531
No1531
Brand NameREVENTA TABLETS 10 MG
IngredientsALENDRONATE SODIUM USP EQ.TO ALENDRONIC ACID 10 MG
Dosage FormTABLET
Primary PackagingBLISTERPACK
Storage
Shelf Life3 YEARS
Pack Size1 BLISTER X 10 TABLETS/BOX
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsIS INDICATED: IN POSTMENOPAUSAL WOMEN FOR THE TREATMENT OF OSTEOPOROSIS TO PREVENT FRACTURES, INCLUDING THOSE OF THE HIP AND SPINE, IN POSTMENOPAUSAL WOMEN WHO ARE AT RISK OF DEVELOPING OSTEOPOROSIS, FOR THE TREATMENT OF OSTEOPOROSIS IN MEN TO PREVENT FRACTURES…
Contraindications
Side Effects
Unit Price
EDL NULL
DescriptionBEIGE COLORED, SQUARE TABLETS, MARKED BISECT LINE ON ONE SIDE AND OTHER SIDE IS PLAIN
Note
License OwnerLAO INTER PHARMA CO.,LTD
ManufacturerGETZ PHARMA (PRIVATE) LIMITED
CountryPAKISTAN
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No06 I 3108/08
FDD Registration Date10-Feb-2023
Expiry Date09-Feb-2026

Back to drug list